Heinrich Heine University Düsseldorf
A German public university in Düsseldorf founded in 1965, known for interdisciplinary research across medicine, sciences, and humanities, with a structured focus on research transfer and entrepreneurship.
Funder analysis
Web-researched analysis· 3 Aug 2026· v7Investment thesis
Heinrich Heine University Düsseldorf (HHU) is a public research university that funds and facilitates applied research, technology transfer, and academic collaboration rather than providing direct equity or grant funding to external startups. Its strategic agenda focuses on leveraging its strengths in medicine, life sciences, and engineering to drive regional innovation through structured research transfer, spin-off support, and participation in large-scale European funding frameworks. HHU acts as a critical node for accessing third-party funded projects, industry partnerships, and early-career researcher networks, making it a partner for R&D collaboration rather than a direct funder of commercial ventures. Credibility: HHU's research transfer office and third-party funded project structures are detailed on its official research portal [1].
Value add
HHU provides access to state-of-the-art research facilities, interdisciplinary collaboration opportunities, and structured support for research transfer and spin-off creation. Its research transfer office assists with patents and industry partnerships. Fit verdict: HHU is a strategic partner for R&D collaboration and technology transfer, not a direct funder. Founder diligence script: 1. Identify the specific HHU department or professor aligned with your technology. 2. Inquire about existing industry partnerships or collaborative projects. 3. Assess the feasibility of a joint research proposal or spin-off structure. 4. Verify eligibility for third-party funding through national or EU programmes facilitated by HHU.
Portfolio focus
HHU's research portfolio includes significant work in plant science (CEPLAS cluster), strong-field laser-plasma physics, and potential therapies for heart attacks and strokes [1]. It also supports research in labor economics and public policy, as evidenced by faculty publications in these areas [3].
Sources
Co-investors
No co-investors named in this fund's research yet.